[The therapeutic contribution of proteomic approaches in cancers]. Article Review uri icon

Overview

MeSH

  • Autoantibodies
  • Biomarkers, Tumor
  • Humans
  • Neoplasm Proteins
  • Prognosis
  • Sensitivity and Specificity

MeSH Major

  • Neoplasms
  • Proteomics

abstract

  • Up to now, there are no protein tumor markers with a specificity and sensitivity sufficient to have a utility in prognosis and early diagnosis of cancer. Recent advances in proteomics approaches have led to the identification of novel tumor markers of cancer that may have a utility in screening strategies and treatment. The purpose of the current review is to describe the major advances in cancer proteomics, especially those related to the study of serum biomarkers, immune-related responses (autoantibodies) and alterations in cellular proteins. Copyright © 2011 Elsevier Masson SAS. All rights reserved.

publication date

  • February 2011

has subject area

  • Autoantibodies
  • Biomarkers, Tumor
  • Humans
  • Neoplasm Proteins
  • Neoplasms
  • Prognosis
  • Proteomics
  • Sensitivity and Specificity

Research

keywords

  • English Abstract
  • Journal Article
  • Review

Identity

Language

  • fre

Digital Object Identifier (DOI)

  • 10.1016/j.gyobfe.2010.12.005

PubMed ID

  • 21317010

Additional Document Info

start page

  • 87

end page

  • 93

volume

  • 39

number

  • 2